Benefits of multistrain bacteria formulations for health

Journal of Functional Foods

Volumn 47, Issue , 2018, Pages 531-546

  Laterza, L ^a   Gibiino, G ^a   Scaldaferri, F ^a   Gasbarrini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Gastrointestinal disease; Gut microbiota; H. pylori; Irritable bowel syndrome; Multistrain probiotics; VSL 3

Indexed keywords

EID: 85048756559     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2018.05.051     Document Type: Article

References (80)

1. Alberda, C., Gramlich, L., Meddings, J., Field, C., McCargar, L., Kutsogiannis, D., Madsen, K., Effects of probiotic therapy in critically ill patients: A randomized, double-blind, placebo-controlled trial. American Journal of Clinical Nutrition 85:3 (2007), 816–823.
2. Allen, S.J., Wareham, K., Wang, D., Bradley, C., Hutchings, H., Harris, W., Mack, D., Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): A randomised, double-blind, placebo-controlled, multicentre trial. Lancet 382:9900 (2013), 1249–1257, 10.1016/S0140-6736(13)61218-0.
3. Bazzocchi, G., Gionchetti, P., Almerigi, P.F., Amadini, C., Campieri, M., Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome. Digestive and Liver Disease 34:Suppl 2 (2002), S48–S53.
4. Begtrup, L.M., de Muckadell, O.B., Kjeldsen, J., Christensen, R.D., Jarbol, D.E., Long-term treatment with probiotics in primary care patients with irritable bowel syndrome–a randomised, double-blind, placebo controlled trial. Scandinavian Journal of Gastroenterology 48:10 (2013), 1127–1135, 10.3109/00365521.2013.825314.
5. Bibiloni, R., Fedorak, R.N., Tannock, G.W., Madsen, K.L., Gionchetti, P., Campieri, M., Sartor, R.B., VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. American Journal of Gastroenterology 100:7 (2005), 1539–1546, 10.1111/j.1572-0241.2005.41794.x.
6. Brigidi, P., Swennen, E., Vitali, B., Rossi, M., Matteuzzi, D., PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption. International Journal of Food Microbiology 81:3 (2003), 203–209.
7. Brigidi, P., Vitali, B., Swennen, E., Bazzocchi, G., Matteuzzi, D., Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Research in Microbiology 152:8 (2001), 735–741.
8. Bucci, C., Tremolaterra, F., Gallotta, S., Fortunato, A., Cappello, C., Ciacci, C., Iovino, P., A pilot study on the effect of a symbiotic mixture in irritable bowel syndrome: An open-label, partially controlled, 6-month extension of a previously published trial. Techniques in Coloproctology 18:4 (2014), 345–353, 10.1007/s10151-013-1055-2.
9. Cappello, C., Tremolaterra, F., Pascariello, A., Ciacci, C., Iovino, P., A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): Effects on symptoms, colonic transit and quality of life. International Journal of Colorectal Disease 28:3 (2013), 349–358, 10.1007/s00384-012-1552-1.
10. Chatterjee, S., Kar, P., Das, T., Ray, S., Gangulyt, S., Rajendiran, C., Mitra, M., Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea. Journal of the Association of Physicians of India 61:10 (2013), 708–712.
11. de Vrese, M., Kristen, H., Rautenberg, P., Laue, C., Schrezenmeir, J., Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. Journal of Dairy Research 78:4 (2011), 396–403, 10.1017/S002202991100063X.
12. de Vrese, M., Schrezenmeir, J., Probiotics, prebiotics, and synbiotics. Advances in Biochemical Engineering/Biotechnology 111 (2008), 1–66, 10.1007/10_2008_097.
13. Delia, P., Sansotta, G., Donato, V., Frosina, P., Messina, G., De Renzis, C., Famularo, G., Use of probiotics for prevention of radiation-induced diarrhea. World Journal of Gastroenterology 13:6 (2007), 912–915.
14. Derwa, Y., Gracie, D.J., Hamlin, P.J., Ford, A.C., Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 46:4 (2017), 389–400, 10.1111/apt.14203.
15. Dhiman, R.K., Rana, B., Agrawal, S., Garg, A., Chopra, M., Thumburu, K.K., Chawla, Y.K., Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. Gastroenterology, 147(6), 2014, 10.1053/j.gastro.2014.08.031 1327–1337e1323.
16. Drouault-Holowacz, S., Bieuvelet, S., Burckel, A., Cazaubiel, M., Dray, X., Marteau, P., A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterologie Clinique et Biologique 32:2 (2008), 147–152, 10.1016/j.gcb.2007.06.001.
17. Ebrahimi-Mameghani, M., Sanaie, S., Mahmoodpoor, A., Hamishehkar, H., Effect of a probiotic preparation (VSL#3) in critically ill patients: A randomized, double-blind, placebo-controlled trial (Pilot Study). Pakistan Journal of Medical Science 29:2 (2013), 490–494.
18. EFSA Panel on Dietetic Products, N.a.A.N., Scientific opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics and reduced risk of acute diarrhoea in patients receiving antibiotics pursuant to article 14 of regulation (EC) No 1924/2006. EFSA Journal, 8(12), 2010, 10.2903/j.efsa.2010.1903.
19. Evans, M., Salewski, R.P., Christman, M.C., Girard, S.A., Tompkins, T.A., Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: A randomised, double-blind, placebo-controlled trial. British Journal of Nutrition 116:1 (2016), 94–103, 10.1017/S0007114516001665.
20. Fedorak, R.N., Feagan, B.G., Hotte, N., Leddin, D., Dieleman, L.A., Petrunia, D.M., Madsen, K., The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease. Clinical Gastroenterology and Hepatology, 13(5), 2015, 10.1016/j.cgh.2014.10.031.
21. Food and Agricultural Organization of the United Nations and World Health Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. (2001). from http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.
22. Frohmader, T.J., Chaboyer, W.P., Robertson, I.K., Gowardman, J., Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: A pilot trial. American Journal of Critical Care 19:3 (2010), e1–e11, 10.4037/ajcc2010976.
23. Gao, X.W., Mubasher, M., Fang, C.Y., Reifer, C., Miller, L.E., Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. American Journal of Gastroenterology 105:7 (2010), 1636–1641, 10.1038/ajg.2010.11.
24. Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K.M., Brigidi, P., Campieri, M., Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial. Gastroenterology 124:5 (2003), 1202–1209.
25. Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Campieri, M., Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 119:2 (2000), 305–309.
26. Gupta, N., Kumar, A., Sharma, P., Garg, V., Sharma, B.C., Sarin, S.K., Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: A randomized trial. Liver International 33:8 (2013), 1148–1157, 10.1111/liv.12172.
27. Han, K., Wang, J., Seo, J.G., Kim, H., Efficacy of double-coated probiotics for irritable bowel syndrome: A randomized double-blind controlled trial. Journal of Gastroenterology 52:4 (2017), 432–443, 10.1007/s00535-016-1224-y.
28. Hauser, G., Salkic, N., Vukelic, K., JajacKnez, A., Stimac, D., Probiotics for standard triple Helicobacter pylori eradication: A randomized, double-blind, placebo-controlled trial. Medicine (Baltimore), 94(17), 2015, e685, 10.1097/MD.0000000000000685.
29. Hickson, M., D'Souza, A.L., Muthu, N., Rogers, T.R., Want, S., Rajkumar, C., Bulpitt, C.J., Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: Randomised double blind placebo controlled trial. BMJ, 335(7610), 2007, 80, 10.1136/bmj.39231.599815.55.
30. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Sanders, M.E., Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11:8 (2014), 506–514, 10.1038/nrgastro.2014.66.
31. Hod, K., Sperber, A.D., Ron, Y., Boaz, M., Dickman, R., Berliner, S., Dekel, R., A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS. Neurogastroenterology and Motility, 29(7), 2017, 10.1111/nmo.13037.
32. Holubar, S.D., Cima, R.R., Sandborn, W.J., Pardi, D.S., Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database of Systematic Reviews, 6, 2010, 10.1002/14651858.CD001176.pub2.
33. Hong, K.S., Kang, H.W., Im, J.P., Ji, G.E., Kim, S.G., Jung, H.C., Kim, J.S., Effect of probiotics on symptoms in korean adults with irritable bowel syndrome. Gut Liver 3:2 (2009), 101–107, 10.5009/gnl.2009.3.2.101.
34. Ianiro, G., Bibbo, S., Gasbarrini, A., Cammarota, G., Therapeutic modulation of gut microbiota: Current clinical applications and future perspectives. Current Drug Targets 15:8 (2014), 762–770.
35. Jafari, E., Vahedi, H., Merat, S., Momtahen, S., Riahi, A., Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating. Archives of Iranian Medicine 17:7 (2014), 466–470 0141707/AIM.003.
36. Jayakumar, S., Carbonneau, M., Hotte, N., Befus, A.D., St Laurent, C., Owen, R., Tandon, P., VSL#3 (R) probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis. Liver International 33:10 (2013), 1470–1477, 10.1111/liv.12280.
37. Kajander, K., Hatakka, K., Poussa, T., Farkkila, M., Korpela, R., A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: A controlled 6-month intervention. Alimentary Pharmacology & Therapeutics 22:5 (2005), 387–394, 10.1111/j.1365-2036.2005.02579.x.
38. Kajander, K., Krogius-Kurikka, L., Rinttila, T., Karjalainen, H., Palva, A., Korpela, R., Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 26:3 (2007), 463–473, 10.1111/j.1365-2036.2007.03391.x.
39. Kajander, K., Myllyluoma, E., Rajilic-Stojanovic, M., Kyronpalo, S., Rasmussen, M., Jarvenpaa, S., Korpela, R., Clinical trial: Multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Alimentary Pharmacology & Therapeutics 27:1 (2008), 48–57, 10.1111/j.1365-2036.2007.03542.x.
40. Ki Cha, B., Mun Jung, S., Hwan Choi, C., Song, I.D., Woong Lee, H., Joon Kim, H., Seo, J.G., The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Clinical Gastroenterology 46:3 (2012), 220–227, 10.1097/MCG.0b013e31823712b1.
41. Kim, H.J., Camilleri, M., McKinzie, S., Lempke, M.B., Burton, D.D., Thomforde, G.M., Zinsmeister, A.R., A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 17:7 (2003), 895–904.
42. Kim, H.J., Vazquez Roque, M.I., Camilleri, M., Stephens, D., Burton, D.D., Baxter, K., Zinsmeister, A.R., A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterology and Motility 17:5 (2005), 687–696, 10.1111/j.1365-2982.2005.00695.x.
43. Kim, S.E., Choi, S.C., Park, K.S., Park, M.I., Shin, J.E., Lee, T.H., Motility, Change of fecal flora and effectiveness of the short-term VSL#3 probiotic treatment in patients with functional constipation. Journal of Neurogastroenterology and Motility 21:1 (2015), 111–120, 10.5056/jnm14048.
44. Koning, C.J., Jonkers, D.M., Stobberingh, E.E., Mulder, L., Rombouts, F.M., Stockbrugger, R.W., The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. American Journal of Gastroenterology 103:1 (2008), 178–189, 10.1111/j.1572-0241.2007.01547.x.
45. Kuhbacher, T., Ott, S.J., Helwig, U., Mimura, T., Rizzello, F., Kleessen, B., Schreiber, S., Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 55:6 (2006), 833–841, 10.1136/gut.2005.078303.
46. Kvasnovsky, C.L., Bjarnason, I., Donaldson, A.N., Sherwood, R.A., Papagrigoriadis, S., A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease. Inflammopharmacology, 2017, 10.1007/s10787-017-0363-y.
47. Lorenzo-Zuniga, V., Llop, E., Suarez, C., Alvarez, B., Abreu, L., Espadaler, J., Serra, J., I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World Journal of Gastroenterology 20:26 (2014), 8709–8716, 10.3748/wjg.v20.i26.8709.
48. Ludidi, S., Jonkers, D.M., Koning, C.J., Kruimel, J.W., Mulder, L., van der Vaart, I.B., Masclee, A.A., Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients. Neurogastroenterology and Motility 26:5 (2014), 705–714, 10.1111/nmo.12320.
49. Lyra, A., Krogius-Kurikka, L., Nikkila, J., Malinen, E., Kajander, K., Kurikka, K., Palva, A., Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterology, 10, 2010, 110, 10.1186/1471-230X-10-110.
50. Mardini, H.E., Grigorian, A.Y., Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: A meta-analysis. Inflammatory Bowel Diseases 20:9 (2014), 1562–1567, 10.1097/MIB.0000000000000084.
51. Michail, S., Kenche, H., Gut microbiota is not modified by randomized, double-blind, placebo-controlled trial of VSL#3 in diarrhea-predominant irritable bowel syndrome. Probiotics and Antimicrobial Proteins 3:1 (2011), 1–7, 10.1007/s12602-010-9059-y.
52. Mimura, T., Rizzello, F., Helwig, U., Poggioli, G., Schreiber, S., Talbot, I.C., Kamm, M.A., Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53:1 (2004), 108–114.
53. Mirghafourvand, M., Homayouni Rad, A., Mohammad Alizadeh Charandabi, S., Fardiazar, Z., Shokri, K., The effect of probiotic yogurt on constipation in pregnant women: a randomized controlled clinical trial. Iranian Red Crescent Medical Journal, 18(11), 2016, 10.5812/ircmj.39870 e39870.
54. Myllyluoma, E., Veijola, L., Ahlroos, T., Tynkkynen, S., Kankuri, E., Vapaatalo, H., Korpela, R., Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy–a placebo-controlled, double-blind randomized pilot study. Alimentary Pharmacology & Therapeutics 21:10 (2005), 1263–1272, 10.1111/j.1365-2036.2005.02448.x.
55. Ng, S.C., Plamondon, S., Kamm, M.A., Hart, A.L., Al-Hassi, H.O., Guenther, T., Knight, S.C., Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis. Inflammatory Bowel Diseases 16:8 (2010), 1286–1298, 10.1002/ibd.21222.
56. Ouwehand, A.C., DongLian, C., Weijian, X., Stewart, M., Ni, J., Stewart, T., Miller, L.E., Probiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study. Vaccine 32:4 (2014), 458–463, 10.1016/j.vaccine.2013.11.053.
57. Pellino, G., Sciaudone, G., Candilio, G., Camerlingo, A., Marcellinaro, R., De Fatico, S., Selvaggi, F., Early postoperative administration of probiotics versus placebo in elderly patients undergoing elective colorectal surgery: A double-blind randomized controlled trial. BMC Surgery, 13(Suppl 2), 2013, S57, 10.1186/1471-2482-13-S2-S57.
58. Plummer, S., Weaver, M.A., Harris, J.C., Dee, P., Hunter, J., Clostridium difficile pilot study: Effects of probiotic supplementation on the incidence of C. difficile diarrhoea. International Microbiology 7:1 (2004), 59–62.
59. Rosania, R., Minenna, M.F., Giorgio, F., Facciorusso, A., De Francesco, V., Hassan, C., Ierardi, E., Probiotic multistrain treatment may eradicate Helicobacter pylori from the stomach of dyspeptics: A placebo-controlled pilot study. Inflammation & Allergy: Drug Targets 11:3 (2012), 244–249.
60. Sampalis, J., Psaradellis, E., Rampakakis, E., Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea - a placebo controlled double-blind randomized, multi-center study. Archives of Medical Science 6:1 (2010), 56–64, 10.5114/aoms.2010.13508.
61. Sanaie, S., Ebrahimi-Mameghani, M., Hamishehkar, H., Mojtahedzadeh, M., Mahmoodpoor, A., Effect of a multispecies probiotic on inflammatory markers in critically ill patients: A randomized, double-blind, placebo-controlled trial. Journal of Research in Medical Sciences 19:9 (2014), 827–833.
62. Sanaie, S., Ebrahimi-Mameghani, M., Mahmoodpoor, A., Shadvar, K., Golzari, S.E., Effect of a probiotic preparation (VSL#3) on cardiovascularrisk parameters in critically-Ill patients. Journal of Cardiovascular Thoracic Research 5:2 (2013), 67–70, 10.5681/jcvtr.2013.014.
63. Selinger, C.P., Bell, A., Cairns, A., Lockett, M., Sebastian, S., Haslam, N., Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. Journal of Hospital Infection 84:2 (2013), 159–165, 10.1016/j.jhin.2013.02.019.
64. Shavakhi, A., Tabesh, E., Yaghoutkar, A., Hashemi, H., Tabesh, F., Khodadoostan, M., Gholamrezaei, A., The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: A randomized placebo-controlled triple-blind study. Helicobacter 18:4 (2013), 280–284, 10.1111/hel.12047.
65. Simren, M., Ohman, L., Olsson, J., Svensson, U., Ohlson, K., Posserud, I., Strid, H., Clinical trial: The effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study. Alimentary Pharmacology & Therapeutics 31:2 (2010), 218–227, 10.1111/j.1365-2036.2009.04183.x.
66. Singh, S., Stroud, A.M., Holubar, S.D., Sandborn, W.J., Pardi, D.S., Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database of Systematic Reviews, 11, 2015, 10.1002/14651858.CD001176.pub3.
67. Sisson, G., Ayis, S., Sherwood, R.A., Bjarnason, I., Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome–a 12 week double-blind study. Alimentary Pharmacology & Therapeutics 40:1 (2014), 51–62, 10.1111/apt.12787.
68. Sondergaard, B., Olsson, J., Ohlson, K., Svensson, U., Bytzer, P., Ekesbo, R., Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized, placebo-controlled trial. Scandinavian Journal of Gastroenterology 46:6 (2011), 663–672, 10.3109/00365521.2011.565066.
69. Song, H.J., Kim, J.Y., Jung, S.A., Kim, S.E., Park, H.S., Jeong, Y., Kim, E.Y., Effect of probiotic Lactobacillus (Lacidofil(R) cap) for the prevention of antibiotic-associated diarrhea: A prospective, randomized, double-blind, multicenter study. Journal of Korean Medical Science 25:12 (2010), 1784–1791, 10.3346/jkms.2010.25.12.1784.
70. Sood, A., Midha, V., Makharia, G.K., Ahuja, V., Singal, D., Goswami, P., Tandon, R.K., The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clinical Gastroenterology and Hepatology 7:11 (2009), 1202–1209, 10.1016/j.cgh.2009.07.016 1209 e1201.
71. Staudacher, H.M., Lomer, M.C.E., Farquharson, F.M., Louis, P., Fava, F., Franciosi, E., Whelan, K., A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores bifidobacterium species: A randomized controlled trial. Gastroenterology 153:4 (2017), 936–947, 10.1053/j.gastro.2017.06.010.
72. Timmerman, H.M., Koning, C.J., Mulder, L., Rombouts, F.M., Beynen, A.C., Monostrain, multistrain and multispecies probiotics–A comparison of functionality and efficacy. International Journal of Food Microbiology 96:3 (2004), 219–233, 10.1016/j.ijfoodmicro.2004.05.012.
73. Toscano, M., De Grandi, R., Pastorelli, L., Vecchi, M., Drago, L., A consumer's guide for probiotics: 10 golden rules for a correct use. Digestive and Liver Disease 49:11 (2017), 1177–1184, 10.1016/j.dld.2017.07.011.
74. Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G.M., Gasbarrini, A., Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: A double-blind, randomized, placebo-controlled study. American Journal of Gastroenterology 105:10 (2010), 2218–2227, 10.1038/ajg.2010.218.
75. Venturi, A., Gionchetti, P., Rizzello, F., Johansson, R., Zucconi, E., Brigidi, P., Campieri, M., Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics 13:8 (1999), 1103–1108.
76. Waitzberg, D.L., Logullo, L.C., Bittencourt, A.F., Torrinhas, R.S., Shiroma, G.M., Paulino, N.P., Teixeira-da-Silva, M.L., Effect of synbiotic in constipated adult women - a randomized, double-blind, placebo-controlled study of clinical response. Clinical Nutrition 32:1 (2013), 27–33, 10.1016/j.clnu.2012.08.010.
77. Williams, E.A., Stimpson, J., Wang, D., Plummer, S., Garaiova, I., Barker, M.E., Corfe, B.M., Clinical trial: A multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Alimentary Pharmacology & Therapeutics 29:1 (2009), 97–103, 10.1111/j.1365-2036.2008.03848.x.
78. Wong, R.K., Yang, C., Song, G.H., Wong, J., Ho, K.Y., Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: A randomized double-blinded placebo study. Digestive Diseases and Sciences 60:1 (2015), 186–194, 10.1007/s10620-014-3299-8.
79. Yoon, J.S., Sohn, W., Lee, O.Y., Lee, S.P., Lee, K.N., Jun, D.W., Seo, J.G., Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Gastroenterology and Hepatology 29:1 (2014), 52–59, 10.1111/jgh.12322.
80. Zaharoni, H., Rimon, E., Vardi, H., Friger, M., Bolotin, A., Shahar, D.R., Probiotics improve bowel movements in hospitalized elderly patients–the PROAGE study. Journal of Nutrition, Health and Aging 15:3 (2011), 215–220.